imipramine has been researched along with Psychomotor Agitation in 10 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
Psychomotor Agitation: A feeling of restlessness associated with increased motor activity. This may occur as a manifestation of nervous system drug toxicity or other conditions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nefazodone-treated patients showed significantly greater improvement in somatic anxiety (HAM-D item 11) ratings than placebo-treated patients from Week 4 through end of treatment (p < or = ." | 2.39 | Response of anxiety and agitation symptoms during nefazodone treatment of major depression. ( Anton, SF; Fawcett, J; Marcus, RN; O'Brien, K; Schwiderski, U, 1995) |
| "Since serotonin system defects occur in Alzheimer's disease (AD), and decreased brain 3H-imipramine binding density, and increased brain and platelet MAO activity are reported also, we studied platelet 3H-imipramine binding density (Bmax) and platelet MAO activity in AD outpatients without antecedent psychiatric disorder." | 1.27 | Platelet tritiated imipramine binding and MAO activity in Alzheimer's disease patients with agitation and delusions. ( Chui, HC; Fredrickson, ER; Pollock, VE; Schneider, LS; Severson, JA; Sloane, RB, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (40.00) | 18.7374 |
| 1990's | 5 (50.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goyal, SN | 1 |
| Upadhya, MA | 1 |
| Kokare, DM | 1 |
| Bhisikar, SM | 1 |
| Subhedar, NK | 1 |
| CHAUCHARD, P | 1 |
| MAZOUE, H | 1 |
| Pöldinger, W | 1 |
| Fawcett, J | 1 |
| Marcus, RN | 1 |
| Anton, SF | 1 |
| O'Brien, K | 1 |
| Schwiderski, U | 1 |
| Tollefson, GD | 1 |
| Greist, JH | 1 |
| Jefferson, JW | 1 |
| Heiligenstein, JH | 1 |
| Sayler, ME | 2 |
| Tollefson, SL | 1 |
| Koback, K | 1 |
| Delini-Stula, A | 1 |
| Mikkelsen, H | 1 |
| Angst, J | 1 |
| Yeragani, VK | 1 |
| Pohl, R | 1 |
| Balon, R | 1 |
| Ramesh, C | 1 |
| Weinberg, P | 1 |
| Beasley, CM | 1 |
| Bosomworth, JC | 1 |
| Wernicke, JF | 1 |
| Klein, DF | 1 |
| Schneider, LS | 1 |
| Severson, JA | 1 |
| Chui, HC | 1 |
| Pollock, VE | 1 |
| Sloane, RB | 1 |
| Fredrickson, ER | 1 |
2 reviews available for imipramine and Psychomotor Agitation
| Article | Year |
|---|---|
Response of anxiety and agitation symptoms during nefazodone treatment of major depression.
Topics: Adult; Antidepressive Agents; Anxiety Disorders; Comorbidity; Depressive Disorder; Double-Blind Meth | 1995 |
Therapeutic efficacy of antidepressants in agitated anxious depression--a meta-analysis of moclobemide studies.
Topics: Adult; Aged; Amitriptyline; Antidepressive Agents; Anxiety Disorders; Benzamides; Clinical Trials as | 1995 |
4 trials available for imipramine and Psychomotor Agitation
| Article | Year |
|---|---|
[Double blind comparison of the antidepressives viloxazine and imipramine (author's transl)].
Topics: Adolescent; Adult; Aged; Anxiety Disorders; Depression; Double-Blind Method; Female; Humans; Imipram | 1982 |
Is baseline agitation a relative contraindication for a selective serotonin reuptake inhibitor: a comparative trial of fluoxetine versus imipramine.
Topics: Adolescent; Adult; Aged; Akathisia, Drug-Induced; Contraindications; Depressive Disorder; Double-Bli | 1994 |
Imipramine-induced jitteriness and decreased serum iron levels.
Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents; Double-Blind Method; Female; Humans; Imiprami | 1992 |
High-dose fluoxetine: efficacy and activating-sedating effects in agitated and retarded depression.
Topics: Adolescent; Adult; Aged; Depression; Drug Administration Schedule; Female; Fluoxetine; Humans; Hypno | 1991 |
4 other studies available for imipramine and Psychomotor Agitation
| Article | Year |
|---|---|
Neuropeptide Y modulates the antidepressant activity of imipramine in olfactory bulbectomized rats: involvement of NPY Y1 receptors.
Topics: Analysis of Variance; Animals; Antidepressive Agents, Tricyclic; Arginine; Behavior, Animal; Depress | 2009 |
[Effect of some thymo-analeptics on the excitability of nerve centers].
Topics: Central Nervous System Stimulants; Imipramine; Iproniazid; Nerve Tissue; Nervous System; Psychomotor | 1962 |
Schizophrenia and bipolar affective disorders: likenesses and differences.
Topics: Acute Disease; Bipolar Disorder; Chlorpromazine; Chronic Disease; Delusions; Depressive Disorder; Hu | 1989 |
Platelet tritiated imipramine binding and MAO activity in Alzheimer's disease patients with agitation and delusions.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Blood Platelets; Carrier Proteins; Delusions; Female; Hu | 1988 |